With help from Lu­l­ule­mon founder’s ven­ture phil­an­thropy, Vi­ta adds sec­ond mus­cu­lar dy­s­tro­phy in­di­ca­tion to line­up

Ear­li­er this year, Lu­l­ule­mon’s founder Chip Wil­son went pub­lic with his rare dis­ease di­ag­no­sis of fa­cioscapu­lo­humer­al mus­cu­lar dy­s­tro­phy type 2, or FSHD type 2, in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER